BIO VITOS PHARMA AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.119 SEK | -8.46% |
|
-11.19% | -50.00% |
| 05-13 | Bio Vitos Pharma AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 02-14 | Bio Vitos Pharma AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Diagnostic & Testing Substances
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 3.63M | - | - | - | - | - | |
| 11.48B | ||||||
| 7.64B | ||||||
| 5.58B | ||||||
| 5.49B | - | - | ||||
| 3.86B |
